[Two particular aspects of Rhodococcus equi infection: malacoplakia and acquisition of resistance to antibiotics].
Rouveix
E
E
Dupont
C
C
Ichai
P
P
Nicolas
M H
MH
Julie
C
C
Lesur
G
G
Dorra
M
M
D042462:4-Quinolones; D000193:Actinomycetales Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008287:Malacoplakia / Q000382:microbiology*; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D016929:Rhodococcus equi / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use*
D042462:4-Quinolones; D000890:Anti-Infective Agents; D012293:Rifampin